InnovAge Holding Corp. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
InnovAge Holding Corp. (INNV) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$5.51 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-09-09
- InnovAge Holding Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was $7.70M.
- InnovAge Holding Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was -$30.09M.
- InnovAge Holding Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-12-31 was $10.15M.
- InnovAge Holding Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was $6.74M.
- InnovAge Holding Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2026 was -$5.51M.
- InnovAge Holding Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2025 was -$35.73M.
- InnovAge Holding Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2024 was -$21.68M.
- InnovAge Holding Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was -$40.98M.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$22.40M derived: sum of 2 quarters · filed 2026-09-09 | -$12.25M derived: sum of 3 quarters · filed 2026-09-09 | -$5.51M 10-K · filed 2026-09-09 |
| 2026-03-31 | -$30.09M 10-Q · filed 2026-05-08 | -$19.95M derived: sum of 2 quarters · filed 2026-05-08 | -$13.21M 10-Q · filed 2026-05-08 | -$18.70M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $10.15M 10-Q · filed 2026-02-03 | $16.89M 10-Q · filed 2026-02-03 | $11.39M derived: sum of 3 quarters · filed 2026-09-09 | -$229.00K derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $6.74M 10-Q · filed 2025-11-04 | $1.25M derived: sum of 2 quarters · filed 2026-09-09 | -$10.38M derived: sum of 3 quarters · filed 2026-09-09 | -$23.82M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | -$5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | -$17.12M derived: sum of 2 quarters · filed 2026-09-09 | -$30.56M derived: sum of 3 quarters · filed 2026-09-09 | -$35.73M 10-K · filed 2026-09-09 |
| 2025-03-31 | -$11.62M 10-Q · filed 2026-05-08 | -$25.07M derived: sum of 2 quarters · filed 2026-05-08 | -$30.23M 10-Q · filed 2026-05-08 | -$32.07M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$13.45M 10-Q · filed 2026-02-03 | -$18.61M 10-Q · filed 2026-02-03 | -$20.45M derived: sum of 3 quarters · filed 2026-02-03 | -$26.39M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$5.17M 10-Q · filed 2025-11-04 | -$7.00M derived: sum of 2 quarters · filed 2025-11-04 | -$12.95M derived: sum of 3 quarters · filed 2025-11-04 | -$16.46M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | -$7.78M derived: sum of 2 quarters · filed 2025-09-09 | -$11.29M derived: sum of 3 quarters · filed 2025-09-09 | -$21.68M 10-K · filed 2025-09-09 |
| 2024-03-31 | -$5.94M 10-Q · filed 2025-05-06 | -$9.46M derived: sum of 2 quarters · filed 2025-05-06 | -$19.85M 10-Q · filed 2025-05-06 | -$31.09M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$3.51M 10-Q · filed 2025-02-04 | -$13.91M 10-Q · filed 2025-02-04 | -$25.15M derived: sum of 3 quarters · filed 2025-02-04 | -$31.86M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | -$10.39M 10-Q · filed 2024-11-05 | -$21.63M derived: sum of 2 quarters · filed 2024-11-05 | -$28.35M derived: sum of 3 quarters · filed 2024-11-05 | -$38.22M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | -$11.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | -$17.96M derived: sum of 2 quarters · filed 2024-09-10 | -$27.83M derived: sum of 3 quarters · filed 2024-09-10 | -$40.98M 10-K · filed 2024-09-10 |
| 2023-03-31 | -$6.72M 10-Q · filed 2024-05-07 | -$16.59M derived: sum of 2 quarters · filed 2024-05-07 | -$29.74M 10-Q · filed 2024-05-07 | -$42.55M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$9.87M 10-Q · filed 2024-02-06 | -$23.02M 10-Q · filed 2024-02-06 | -$35.84M derived: sum of 3 quarters · filed 2024-02-06 | -$38.70M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | -$13.15M 10-Q · filed 2023-11-07 | -$25.97M derived: sum of 2 quarters · filed 2023-11-07 | -$28.84M derived: sum of 3 quarters · filed 2023-11-07 | -$27.59M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$12.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | -$15.68M derived: sum of 2 quarters · filed 2023-09-12 | -$14.43M derived: sum of 3 quarters · filed 2023-09-12 | -$6.84M 10-K · filed 2023-09-12 |
| 2022-03-31 | -$2.87M 10-Q · filed 2023-05-09 | -$1.62M derived: sum of 2 quarters · filed 2023-05-09 | $5.97M 10-Q · filed 2023-05-09 | $12.47M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.25M 10-Q · filed 2023-02-07 | $8.84M 10-Q · filed 2023-02-07 | $15.33M derived: sum of 3 quarters · filed 2023-02-07 | $4.74M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $7.59M 10-Q · filed 2022-11-08 | $14.08M derived: sum of 2 quarters · filed 2022-11-08 | $3.48M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | -$4.11M derived: sum of 2 quarters · filed 2022-09-13 | -$44.30M 10-K · filed 2022-09-13 | |
| 2021-03-31 | -$10.60M 10-Q · filed 2022-05-10 | -$50.79M 10-Q · filed 2022-05-10 | ||
| 2020-09-30 | -$49.80M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |